TherapeuticsMD, Inc. (NASDAQ:TXMD) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer James D’Arecca - Chief Financial Officer Dawn Halkuff - Chief Commercial Officer Mitch Krassan - Chief Strategy and Performance Officer Conference Call Participants Jen Kim - Cantor Fitzgerald Stacy Ku - Cowen and Company Douglas Tsao - H.C. Wainwright Annabel Samimy - Stifel Financial Corp. Operator ...

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 THERAPEUTICSMD, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 | Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ...

TherapeuticsMD® For Her. For Life. 2Q 2020 Earnings August 6, 2020 FOR INVESTOR PRESENTATION PURPOSES ONLY. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or "the Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from________ to ___________ Commission File No. 001-00100 THERAPEUTICSMD, INC. (Exact Name of Registrant as Specified in Its Charter) Nevada 87-0233535 (State or O ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q1 2020 Earnings Conference Call May 6, 2020 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Robert Finizio - Chief Executive Officer Dawn Halkuff - Chief Commercial Officer Mitchell Krassan - Chief Strategy & Performance Officer Conference Call Participants Jennifer Kim - Cantor Fitzgerald. Stacy Ku - Cowen & Company Annabel Samimy - Stifel Doug Tsao - H.C. Wainwright Ahu Demir - Noble Capital Dana Flanders - Guggenheim Operator Good ...

TherapeuticsMD® 1Q 2020 Earnings May 6, 2020 Building the Premier Women's Health Company Forward- Looking Statements 2 This presentation by TherapeuticsMD, Inc. (referred to as "we," "our," or "the Company") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, project, believ ...

Commission File Number 001-00100 TherapeuticsMD, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ________________________ (Exact Name of Registrant as Specified in Its Charter) (State or Other ...

TherapeuticsMD, Inc. (NASDAQ:TXMD) Q4 2019 Earnings Conference Call February 20, 2020 8:30 AM ET Company Participants Nichol Ochsner - VP, IR Robert Finizio - CEO Dawn Halkuff - Chief Commercial Officer Dan Cartwright - CFO Conference Call Participants Louise Chen - Cantor Fitzgerald Dana Flanders - Guggenheim Annabel Samimy - Stifel Larry Solow - CJS Ken Cacciatore - Cowen & Company Douglas Tsao - H.C. Wainwright Operator Good morning, ladies and gentlemen. Thank you for joining us for the TherapeuticsMD F ...

TherapeuticsMD® 4Q 2019 Earnings February 20, 2020 Building the Premier Women's Health Company Forward- Looking Statements 2 This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, project, believe or anti ...

1 Investor Presentation November 19, 2019 Building a Premier Women's Health Portfolio TherapeuticsMD® For Her. For Life. Forward-Looking Statements This presentation by TherapeuticsMD, Inc. (referred to as "we" and "our") may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, as well as statements, other than historical facts, that address activities, events or developments that we intend, expect, p ...